IN8bio

About IN8bio

IN8bio is a leading clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell therapies for solid and hematological tumors. Their mission is to achieve 'CANCER ZERO'—the elimination of all cancer cells in every patient—through innovative cellular therapies using allogeneic, autologous, iPSC, and genetically modified approaches.

Products & Services

INB-400:A Phase 2 clinical trial product for the treatment of newly diagnosed glioblastoma (GBM).

DeltEx™ Platform:A technology platform for developing ex vivo expanded and activated gamma-delta T cell therapies, targeting a wide range of solid and hematologic malignancies.

Preclinical and Discovery-Stage Programs:A broad portfolio focused on addressing solid tumors.

Specialties

Gamma-delta T cell therapies Cancer cell therapy Solid and hematological tumor treatments Allogeneic and autologous cell therapies Genetic engineering of immune cells iPSC-derived therapies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 40200000 MR: - FA: up to $40.2 million FAN: 40200000	D: 2025-12-19 FD: 2025-12-19	4 investors
2	RT: Private Placement T: - FT: Private Placement	A: 12400000 MR: - FA: $12.4 million FAN: 12400000	D: 2024-10-01 FD: 2024-10-01	3 investors
3	RT: Private Placement T: - FT: Private Placement	A: 14400000 MR: - FA: 14.4 million FAN: 14400000	D: 2023-12-11 FD: 2023-12-11	1 investors

Private Placement Latest

2025-12-19

$40.2M

4 investors (Pro only)

Private Placement 2024-10-01

$12.4M

Private Placement 2023-12-11

$14.4M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

W

William Ho

Director, President, CEO, and Co-Founder

L

Lawrence Lamb

Co-founder and Leader in Gamma-Delta T Cells

K

Kate Rochlin

Chief Operating Officer

P

Patrick McCall

Chief Financial Officer

S

Stacey Bilinski

Vice President, Clinical Operations

B

Bianca Santomasso

Neuro-Oncologist

View 17 more team members with Pro

Unlock Full Team Directory

Recent News

IN8bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised